These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35579154)

  • 21. Long non-coding RNA FENDRR attenuates the stemness of non-small cell lung cancer cells via decreasing multidrug resistance gene 1 (MDR1) expression through competitively binding with RNA binding protein HuR.
    Gong F; Dong D; Zhang T; Xu W
    Eur J Pharmacol; 2019 Jun; 853():345-352. PubMed ID: 30981768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The long non-coding RNA Fendrr links epigenetic control mechanisms to gene regulatory networks in mammalian embryogenesis.
    Grote P; Herrmann BG
    RNA Biol; 2013 Oct; 10(10):1579-85. PubMed ID: 24036695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fendrr involves in the pathogenesis of cardiac fibrosis via regulating miR-106b/SMAD3 axis.
    Gong L; Zhu L; Yang T
    Biochem Biophys Res Commun; 2020 Mar; 524(1):169-177. PubMed ID: 31982134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LncRNA FENDRR represses proliferation, migration and invasion through suppression of survivin in cholangiocarcinoma cells.
    Qin X; Lu M; Zhou Y; Li G; Liu Z
    Cell Cycle; 2019 Apr; 18(8):889-897. PubMed ID: 30983519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Emerging Role of Thymopoietin-Antisense RNA 1 as Long Noncoding RNA in the Pathogenesis of Human Cancers.
    Zheng Q; Jia J; Zhou Z; Chu Q; Lian W; Chen Z
    DNA Cell Biol; 2021 Jul; 40(7):848-857. PubMed ID: 34096793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CASC2: An emerging tumour-suppressing long noncoding RNA in human cancers and melanoma.
    Yu X; Zheng H; Tse G; Zhang L; Wu WKK
    Cell Prolif; 2018 Dec; 51(6):e12506. PubMed ID: 30094876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long Non-Coding RNA
    Szafranski P; Stankiewicz P
    Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33513839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LncRNA FENDRR Upregulation Promotes Hepatic Carcinoma Cells Apoptosis by Targeting miR-362-5p Via NPR3 and p38-MAPK Pathway.
    Qian G; Jin X; Zhang L
    Cancer Biother Radiopharm; 2020 Nov; 35(9):629-639. PubMed ID: 32251605
    [No Abstract]   [Full Text] [Related]  

  • 29. DLX6-AS1 is a potential biomarker and therapeutic target in cancer initiation and progression.
    Zheng Q; Gu X; Yang Q; Chu Q; Dai Y; Chen Z
    Clin Chim Acta; 2021 Jun; 517():1-8. PubMed ID: 33607068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lung-specific distant enhancer cis regulates expression of FOXF1 and lncRNA FENDRR.
    Szafranski P; Gambin T; Karolak JA; Popek E; Stankiewicz P
    Hum Mutat; 2021 Jun; 42(6):694-698. PubMed ID: 33739555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dysregulated expression and functions of microRNA-330 in cancers: A potential therapeutic target.
    Jafarzadeh A; Paknahad MH; Nemati M; Jafarzadeh S; Mahjoubin-Tehran M; Rajabi A; Shojaie L; Mirzaei H
    Biomed Pharmacother; 2022 Feb; 146():112600. PubMed ID: 34968919
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DLEU2: A Meaningful Long Noncoding RNA in Oncogenesis.
    Xu W; Wang B; Cai Y; Guo C; Liu K; Yuan C
    Curr Pharm Des; 2021; 27(20):2337-2343. PubMed ID: 33106136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LncRNAs with miRNAs in regulation of gastric, liver, and colorectal cancers: updates in recent years.
    Tam C; Wong JH; Tsui SKW; Zuo T; Chan TF; Ng TB
    Appl Microbiol Biotechnol; 2019 Jun; 103(12):4649-4677. PubMed ID: 31062053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long non‑coding RNAs in gallbladder cancer: From mechanisms to therapeutic opportunities (Review).
    He Y; Du X; Yuan F; Yan C; Chen M; Han L; Sun J
    Int J Oncol; 2024 Feb; 64(2):. PubMed ID: 38099359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systematic identification of cancer-related long noncoding RNAs and aberrant alternative splicing of quintuple-negative lung adenocarcinoma through RNA-Seq.
    Zhang L; Li S; Choi YL; Lee J; Gong Z; Liu X; Pei Y; Jiang A; Ye M; Mao M; Zhang X; Kim J; Chen R
    Lung Cancer; 2017 Jul; 109():21-27. PubMed ID: 28577945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dysregulated expression of long noncoding RNAs in gynecologic cancers.
    Hosseini ES; Meryet-Figuiere M; Sabzalipoor H; Kashani HH; Nikzad H; Asemi Z
    Mol Cancer; 2017 Jun; 16(1):107. PubMed ID: 28637507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. KCNQ1OT1: An Oncogenic Long Noncoding RNA.
    Cagle P; Qi Q; Niture S; Kumar D
    Biomolecules; 2021 Oct; 11(11):. PubMed ID: 34827600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RNA epigenetics in pulmonary diseases: Insights into methylation modification of lncRNAs in lung cancer.
    Jiang J; Duan M; Wang Z; Lai Y; Zhang C; Duan C
    Biomed Pharmacother; 2024 Jun; 175():116704. PubMed ID: 38749181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long non-coding RNA FENDRR inhibits proliferation and invasion of hepatocellular carcinoma by down-regulating glypican-3 expression.
    Wang B; Xian J; Zang J; Xiao L; Li Y; Sha M; Shen M
    Biochem Biophys Res Commun; 2019 Jan; 509(1):143-147. PubMed ID: 30573358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FENDRR suppresses cervical cancer proliferation and invasion by targeting miR-15a/b-5p and regulating TUBA1A expression.
    Zhu Y; Zhang X; Wang L; Zhu X; Xia Z; Xu L; Xu J
    Cancer Cell Int; 2020; 20():152. PubMed ID: 32398968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.